Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul-Aug;39(4):e115-e117.
doi: 10.1097/IOP.0000000000002373. Epub 2023 Mar 9.

Elevated Intraocular Pressure in Periorbital Sweet's Syndrome

Jamie A Keen  1 , Mark D Fisher  2 , Caroline Y Yu  1 , Brian L Swick  3   4 , Erin M Shriver  1
Affiliations

Elevated Intraocular Pressure in Periorbital Sweet's Syndrome

Jamie A Keen et al. Ophthalmic Plast Reconstr Surg. 2023 Jul-Aug.

Abstract

A 66-year-old immunocompromised man presented with cellulitis around the left eye that was initially concerning for necrotizing fasciitis. Exam findings were remarkable for exquisite periocular tenderness with rigid, immobile eyelids resulting from severe erythema, edema, and induration. Given the concern for orbital compartment syndrome and a necrotizing infection, the patient was taken urgently to the operating room for debridement of the eyelid skin as well as an urgent lateral canthotomy and cantholysis. His eye exam revealed 360° of hemorrhagic chemosis, no relative afferent pupillary defect, and an ipsilateral elevated intraocular pressure of 35 mm Hg. No visual acuity measurement could be obtained secondary to the patient's altered mental status. His intraocular pressure normalized after treatment with antihypertensive drops and further extension of the canthotomy. Histopathological analysis showed extensive neutrophilic infiltrate of the dermis which was compatible with a diagnosis of Sweet's syndrome.

PubMed Disclaimer

Conflict of interest statement

E.M.S. has served as an advisor and consultant for Horizon Therapeutics and as an advisor for Tarsus Pharmaceuticals. No other authors have any financial disclosures or conflicts of interest.

References

    1. Villarreal-Villarreal CD, Ocampo-Candiani J, Villarreal-Martinez A. Sweet syndrome: a review and update. Actas Dermosifiliogr. 2016;107:369–378.
    1. Gottlieb CC, Mishra A, Belliveau D, et al. Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): new cases and review of the literature. Surv Ophthalmol Inter Rev J. 2008;53:219–226.
    1. Jang Y, Jang K, Kim N, et al. Blindness in Sweet’s syndrome. Korean J Ophthalmol. 2017;31:570–571.
    1. Morgan KW, Callen JP. Sweet’s syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate. J Am Acad Dermatol. 2001;45:590–595.
    1. Khatri ML, Taha M. Sweet’s syndrome associated with myelodysplastic syndrome presenting as periorbital cellulitis. Int J Dermatol. 2007;46:496–499.

Publication types

LinkOut - more resources